Ubs Asset Management Americas Inc Precision Biosciences Inc Transaction History

Ubs Asset Management Americas Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.15 - $3.34 $57,902 - $168,169	-50,350 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$9.18 - $14.15 $30,339 - $46,765	-3,305 Reduced 6.16%	50,350 $581,000
Q2 2021 Aug 16, 2021	BUY	$8.07 - $12.52 $60,161 - $93,336	7,455 Added 16.14%	53,655 $671,000
Q1 2021 May 14, 2021	BUY	$8.57 - $15.79 $106,268 - $195,796	12,400 Added 36.69%	46,200 $478,000
Q4 2020 Mar 01, 2021	BUY	$5.98 - $12.47 $44,850 - $93,525	7,500 Added 28.52%	33,800 $281,000
Q2 2020 Aug 14, 2020	BUY	$4.66 - $8.7 $122,558 - $228,809	26,300 New	26,300 $219,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $744M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.